Trial Profile
The pharmacokinetics of telaprevir and selected antiretroviral medications in HCV/HIV co-infected patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2012
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Antiretrovirals; Atazanavir/ritonavir; Efavirenz; Peginterferon; Ribavirin
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- Sponsors Vertex Pharmaceuticals
- 25 Nov 2012 New trial record